September 24, 2008
Salmeterol and fluticasone propionate can slow the rate of decline in lung function in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD), researchers report in the Aug. 15 issue of the American Journal of Respiratory and Critical Care Medicine.
 |
September 24, 2008
Salmeterol and fluticasone propionate can slow the rate of decline in lung function in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD), researchers report in the Aug. 15 issue of the American Journal of Respiratory and Critical Care Medicine.
|
September 24, 2008
Postpubertal females with asthma have more severe airway responsiveness compared with males and the responsiveness is associated with gender-specific factors, researchers report in the Aug. 15 issue of the American Journal of Respiratory and Critical Care Medicine.
|
September 24, 2008
Specific types of comorbidities and increasing numbers of comorbidities worsen fatigue severity and symptom scores in HIV/AIDS patients, and health care providers must be able to identify causes of fatigue to intervene more effectively, according to study findings published in the August issue of Applied Nursing Research.
|
September 24, 2008
Breast cancer patients treated with systemic therapy who survive disease-free for five years have a substantial risk of cancer recurring up to 10 years after treatment, and late recurrence is associated with certain tumor characteristics, according to a report published online Aug. 11 in the Journal of the National Cancer Institute.
|
September 24, 2008
From 1995 to 2002, receipt of contraceptive services dramatically increased among U.S. women aged 15 to 44, according to research published online Aug. 13 in the American Journal of Public Health.
|
September 10, 2008
Patients who lose weight after being newly diagnosed with type 2 diabetes have better glycemic and blood pressure control than patients who maintain a stable weight or gain weight, even if they later regain the weight, according to a report released online in advance of publication in an upcoming issue of Diabetes Care.
|
September 10, 2008
In women with metastatic breast cancer, the risk of cardiotoxicity from epirubicin treatment is higher than previously expected, but an increasing dose is also associated with improved overall survival, according to a report published in the Aug. 6 issue of the Journal of the National Cancer Institute.
|
September 10, 2008
In a mouse model of metastatic breast cancer, lapatinib reduces the number of large brain metastases, according to research published in the Aug. 6 issue of the Journal of the National Cancer Institute.
|
| 
